Selected research
Market Structure
Global Intracardiac Drug Coated Balloons Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Intracardiac Drug Coated Balloons market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Intracardiac Drug Coated Balloons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Intracardiac Drug Coated Balloons include Yinyi Biotech, Yingsheng Medical, Shenqi Medical, Lepu Medical, DK Medical Technology, Cardionovum, Barty Medical and B. Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Intracardiac Drug Coated Balloons market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Intracardiac Drug Coated Balloons and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Intracardiac Drug Coated Balloons sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intracardiac Drug Coated Balloons market size, projected growth trends, production technologies, key applications, and end-use industries.
Intracardiac Drug Coated Balloons Segment by Company
Yinyi Biotech
Yingsheng Medical
Shenqi Medical
Lepu Medical
DK Medical Technology
Cardionovum
Barty Medical
B. Braun
Intracardiac Drug Coated Balloons Segment by Type
Spray Coating
Dip Coating
Others
Intracardiac Drug Coated Balloons Segment by Application
In Stent Restenosis (ISR)
Coronary Bifurcation Lesion (CBL)
Others
Intracardiac Drug Coated Balloons Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intracardiac Drug Coated Balloons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intracardiac Drug Coated Balloons and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intracardiac Drug Coated Balloons.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Intracardiac Drug Coated Balloons market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intracardiac Drug Coated Balloons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intracardiac Drug Coated Balloons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Intracardiac Drug Coated Balloons in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Spray Coating
- Dip Coating
- Others
Applications
- In Stent Restenosis (ISR)
- Coronary Bifurcation Lesion (CBL)
- Others
Companies covered
- Yinyi Biotech
- Yingsheng Medical
- Shenqi Medical
- Lepu Medical
- DK Medical Technology
- Cardionovum
- Barty Medical
- B. Braun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Intracardiac Drug Coated Balloons Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Intracardiac Drug Coated Balloons Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Intracardiac Drug Coated Balloons Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Intracardiac Drug Coated Balloons Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Intracardiac Drug Coated Balloons Market Dynamics
- 2.1 Intracardiac Drug Coated Balloons Industry Trends
- 2.2 Intracardiac Drug Coated Balloons Industry Drivers
- 2.3 Intracardiac Drug Coated Balloons Industry Opportunities and Challenges
- 2.4 Intracardiac Drug Coated Balloons Industry Restraints
3 Intracardiac Drug Coated Balloons Market by Manufacturers
- 3.1 Global Intracardiac Drug Coated Balloons Revenue by Manufacturers (2021-2026)
- 3.2 Global Intracardiac Drug Coated Balloons Sales by Manufacturers (2021-2026)
- 3.3 Global Intracardiac Drug Coated Balloons Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Intracardiac Drug Coated Balloons Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Intracardiac Drug Coated Balloons Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Intracardiac Drug Coated Balloons Manufacturers, Product Type & Application
- 3.7 Global Intracardiac Drug Coated Balloons Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Intracardiac Drug Coated Balloons Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Intracardiac Drug Coated Balloons Players Market Share by Revenue in 2025
- 3.8.3 2025 Intracardiac Drug Coated Balloons Tier 1, Tier 2, and Tier 3
4 Intracardiac Drug Coated Balloons Market by Type
- 4.1 Intracardiac Drug Coated Balloons Type Introduction
- 4.1.1 Spray Coating
- 4.1.2 Dip Coating
- 4.1.3 Others
- 4.2 Global Intracardiac Drug Coated Balloons Sales by Type
- 4.2.1 Global Intracardiac Drug Coated Balloons Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Intracardiac Drug Coated Balloons Sales by Type (2021-2032)
- 4.2.3 Global Intracardiac Drug Coated Balloons Sales Market Share by Type (2021-2032)
- 4.3 Global Intracardiac Drug Coated Balloons Revenue by Type
- 4.3.1 Global Intracardiac Drug Coated Balloons Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Intracardiac Drug Coated Balloons Revenue by Type (2021-2032)
- 4.3.3 Global Intracardiac Drug Coated Balloons Revenue Market Share by Type (2021-2032)
5 Intracardiac Drug Coated Balloons Market by Application
- 5.1 Intracardiac Drug Coated Balloons Application Introduction
- 5.1.1 In Stent Restenosis (ISR)
- 5.1.2 Coronary Bifurcation Lesion (CBL)
- 5.1.3 Others
- 5.2 Global Intracardiac Drug Coated Balloons Sales by Application
- 5.2.1 Global Intracardiac Drug Coated Balloons Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Intracardiac Drug Coated Balloons Sales by Application (2021-2032)
- 5.2.3 Global Intracardiac Drug Coated Balloons Sales Market Share by Application (2021-2032)
- 5.3 Global Intracardiac Drug Coated Balloons Revenue by Application
- 5.3.1 Global Intracardiac Drug Coated Balloons Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Intracardiac Drug Coated Balloons Revenue by Application (2021-2032)
- 5.3.3 Global Intracardiac Drug Coated Balloons Revenue Market Share by Application (2021-2032)
6 Global Intracardiac Drug Coated Balloons Sales by Region
- 6.1 Global Intracardiac Drug Coated Balloons Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Intracardiac Drug Coated Balloons Sales by Region (2021-2032)
- 6.2.1 Global Intracardiac Drug Coated Balloons Sales by Region (2021-2026)
- 6.2.2 Global Intracardiac Drug Coated Balloons Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Intracardiac Drug Coated Balloons Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Intracardiac Drug Coated Balloons Revenue by Region
- 7.1 Global Intracardiac Drug Coated Balloons Revenue by Region
- 7.1.1 Global Intracardiac Drug Coated Balloons Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Intracardiac Drug Coated Balloons Revenue by Region (2021-2026)
- 7.1.3 Global Intracardiac Drug Coated Balloons Revenue by Region (2027-2032)
- 7.1.4 Global Intracardiac Drug Coated Balloons Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Intracardiac Drug Coated Balloons Revenue (2021-2032)
- 7.2.2 North America Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Intracardiac Drug Coated Balloons Revenue (2021-2032)
- 7.3.2 Europe Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Intracardiac Drug Coated Balloons Revenue (2021-2032)
- 7.4.2 Asia-Pacific Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Intracardiac Drug Coated Balloons Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yinyi Biotech
- 8.1.1 Yinyi Biotech Company Information
- 8.1.2 Yinyi Biotech Business Overview
- 8.1.3 Yinyi Biotech Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yinyi Biotech Intracardiac Drug Coated Balloons Product Portfolio
- 8.1.5 Yinyi Biotech Recent Developments
- 8.2 Yingsheng Medical
- 8.2.1 Yingsheng Medical Company Information
- 8.2.2 Yingsheng Medical Business Overview
- 8.2.3 Yingsheng Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Yingsheng Medical Intracardiac Drug Coated Balloons Product Portfolio
- 8.2.5 Yingsheng Medical Recent Developments
- 8.3 Shenqi Medical
- 8.3.1 Shenqi Medical Company Information
- 8.3.2 Shenqi Medical Business Overview
- 8.3.3 Shenqi Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shenqi Medical Intracardiac Drug Coated Balloons Product Portfolio
- 8.3.5 Shenqi Medical Recent Developments
- 8.4 Lepu Medical
- 8.4.1 Lepu Medical Company Information
- 8.4.2 Lepu Medical Business Overview
- 8.4.3 Lepu Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lepu Medical Intracardiac Drug Coated Balloons Product Portfolio
- 8.4.5 Lepu Medical Recent Developments
- 8.5 DK Medical Technology
- 8.5.1 DK Medical Technology Company Information
- 8.5.2 DK Medical Technology Business Overview
- 8.5.3 DK Medical Technology Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 DK Medical Technology Intracardiac Drug Coated Balloons Product Portfolio
- 8.5.5 DK Medical Technology Recent Developments
- 8.6 Cardionovum
- 8.6.1 Cardionovum Company Information
- 8.6.2 Cardionovum Business Overview
- 8.6.3 Cardionovum Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cardionovum Intracardiac Drug Coated Balloons Product Portfolio
- 8.6.5 Cardionovum Recent Developments
- 8.7 Barty Medical
- 8.7.1 Barty Medical Company Information
- 8.7.2 Barty Medical Business Overview
- 8.7.3 Barty Medical Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Barty Medical Intracardiac Drug Coated Balloons Product Portfolio
- 8.7.5 Barty Medical Recent Developments
- 8.8 B. Braun
- 8.8.1 B. Braun Company Information
- 8.8.2 B. Braun Business Overview
- 8.8.3 B. Braun Intracardiac Drug Coated Balloons Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 B. Braun Intracardiac Drug Coated Balloons Product Portfolio
- 8.8.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Intracardiac Drug Coated Balloons Value Chain Analysis
- 9.1.1 Intracardiac Drug Coated Balloons Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Intracardiac Drug Coated Balloons Production Mode & Process
- 9.2 Intracardiac Drug Coated Balloons Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Intracardiac Drug Coated Balloons Distributors
- 9.2.3 Intracardiac Drug Coated Balloons Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst